FY23 Corporate Strategy and Sustainability Journey

We continue to progress on our journey in two horizons... Horizon 1 - Growing the core Horizon 2 - Building the future Generics Branded Generics API Immuno- oncology NCES Disease Management CDMO (small and large mol.) Nutraceuticals Biosimilars OTC Biologics & CGT Digital Services D2C (drivers in short to medium-term) (drivers in short to long-term) D2C: Direct-to-customer; CGT: Cell & Gene therapy; OTC: Over the counter 14 © copyright Dr. Reddy's Ltd.

View entire presentation